Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

Treatment Patterns in Patients With Prostate Cancer and Bone Metastasis Among US Community-based Urology Group Practices

(2012) Stephen J. Freedland et al.   UROLOGY

Treatment Persistence With Monthly Zoledronic Acid is Associated With Lower Risk and Frequency of Skeletal Complications in Patients With Breast Cancer and Bone Metastasis

(2011) Hind T. Hatoum et al.   Clinical Breast Cancer

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

(2011) Catherine H. Van Poznak et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers

(2011) Henry J. Henk et al.   JOURNAL OF MEDICAL ECONOMICS

Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastases

(2011) Henry J. Henk et al.   JOURNAL OF MEDICAL ECONOMICS

The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population

(2010) N V Velde et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases

(2008) Hind T. Hatoum et al.   CANCER

Use of Intravenous Bisphosphonates in Older Women with Breast Cancer

(2008) S. H. Giordano et al.   ONCOLOGIST